NCT04884490View on ClinicalTrials.gov

The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

October 14, 2021

Study Completion Date

November 14, 2021

Conditions
COVID-19 Pneumonia
Interventions
DRUG

Co-trimoxazole

Tab. Co-trimoxazole 960 mg (trimethoprim 160mg + sulphamethoxazole 800mg) thrice (8 hourly) daily for 7 days orally.

DRUG

Placebo

Placebo thrice (8 hourly) daily for 7 days orally.

Trial Locations (1)

1200

Bangabandhu Sheikh Mujib Medical University, Dhaka

All Listed Sponsors
lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER